Pharmaceutical firm targets to reach whole year profit of 360b dong

Hau Giang Pharmaceutical Joint Stock Co (coded DHG) planned to hold the annual shareholders meeting on April 29, 2011, in which the company would seek approval among the participants for 2011 business plan.



In details, DHG aimed to archive total production output of 2.607 trillion dong, net revenue of 2.24 trillion dong, pre-tax profit of 360 billion dong and export turnover of $1.5 million.



By the end of February, the pharmaceutical firm reported gaining production output of 444 billion dong. The accumulative net revenue was estimated at 319 billion dong and pre-tax profit of 68 billion dong.



In terms of market share, DHG was ranked at the third place in Vietnamese markets, after two international groups of Sanofi-Aventis (France) and GSK (the UK).



In 2011, the company will concentrate on investing in new pharmaceutical plant. DHG has already finished compensation works for the local residents, and was preparing for ground levelling so as to kick off the construction in early Q2.

Tags: Vietnam business, Vietnam stock news

Posted by VBN on Mar 21 2011. Filed under Enterprises. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry